Copyright Reports & Markets. All rights reserved.

Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Market Report 2019 by Manufacturer, Region, Type and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Squamous Non-Small Cell Lung Cancer Therapeutics Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 BMS-906024
      • 2.1.2 Buparlisib Hydrochloride
      • 2.1.3 FP-1039
      • 2.1.4 Ipilimumab
      • 2.1.5 JNJ-42756493
      • 2.1.6 Lenvatinib
      • 2.1.7 Others
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 BMS-906024
      • 2.2.2 Buparlisib Hydrochloride
      • 2.2.3 FP-1039
      • 2.2.4 Ipilimumab
      • 2.2.5 JNJ-42756493
      • 2.2.6 Lenvatinib
      • 2.2.7 Others

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Research Center
      • 3.1.2 Hospital
      • 3.1.3 Clinic

    4 Manufacturers Profiles/Analysis

    • 4.1 Ascenta Therapeutics, Inc.
      • 4.1.1 Ascenta Therapeutics, Inc. Profiles
      • 4.1.2 Ascenta Therapeutics, Inc. Product Information
      • 4.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.1.4 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.2 AstraZeneca Plc
      • 4.2.1 AstraZeneca Plc Profiles
      • 4.2.2 AstraZeneca Plc Product Information
      • 4.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.2.4 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.3 AVEO Pharmaceuticals, Inc.
      • 4.3.1 AVEO Pharmaceuticals, Inc. Profiles
      • 4.3.2 AVEO Pharmaceuticals, Inc. Product Information
      • 4.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.3.4 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.4 Bayer AG
      • 4.4.1 Bayer AG Profiles
      • 4.4.2 Bayer AG Product Information
      • 4.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.4.4 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.5 BIND Therapeutics, Inc.
      • 4.5.1 BIND Therapeutics, Inc. Profiles
      • 4.5.2 BIND Therapeutics, Inc. Product Information
      • 4.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.5.4 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.6 Boehringer Ingelheim GmbH
      • 4.6.1 Boehringer Ingelheim GmbH Profiles
      • 4.6.2 Boehringer Ingelheim GmbH Product Information
      • 4.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.6.4 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.7 Bristol-Myers Squibb Company
      • 4.7.1 Bristol-Myers Squibb Company Profiles
      • 4.7.2 Bristol-Myers Squibb Company Product Information
      • 4.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.7.4 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.8 Eli Lilly and Company
      • 4.8.1 Eli Lilly and Company Profiles
      • 4.8.2 Eli Lilly and Company Product Information
      • 4.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.8.4 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.9 F. Hoffmann-La Roche Ltd.
      • 4.9.1 F. Hoffmann-La Roche Ltd. Profiles
      • 4.9.2 F. Hoffmann-La Roche Ltd. Product Information
      • 4.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.9.4 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.10 Five Prime Therapeutics, Inc.
      • 4.10.1 Five Prime Therapeutics, Inc. Profiles
      • 4.10.2 Five Prime Therapeutics, Inc. Product Information
      • 4.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Performance
      • 4.10.4 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Business Development and Market Status
    • 4.11 Genentech, Inc.
    • 4.12 Incyte Corporation
    • 4.13 Johnson & Johnson
    • 4.14 MacroGenics, Inc.
    • 4.15 Novartis AG
    • 4.16 Oncogenex Pharmaceuticals, Inc.
    • 4.17 PsiOxus Therapeutics Limited

    5 Market Performance for Manufacturers

    • 5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Market Share by Manufacturers 2014-2019
    • 5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Market Share by Manufacturers 2014-2019
    • 5.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
    • 5.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.1.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.1.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.1.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.2.2 USA Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.2.3 USA Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.2.4 USA Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.3.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.3.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.3.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.4.2 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.4.3 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.4.4 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.5.2 Korea Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.5.3 Korea Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.5.4 Korea Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.6.2 India Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.6.3 India Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.6.4 India Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.7.2 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.7.3 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.7.4 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.8.2 South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.8.3 South America Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) of Manufacturers 2014-2019
      • 6.8.4 South America Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin of Manufacturers 2014-2019
      • 6.8.5 Market Concentration

    7 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Performance (Sales Point)

    • 7.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Market Share by Regions 2014-2019
    • 7.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (M USD) and Market Share by Regions 2014-2019
    • 7.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) by Regions 2014-2019
    • 7.4 Global Squamous Non-Small Cell Lung Cancer Therapeutics Gross Margin by Regions 2014-2019

    8 Development Trend for Regions (Sales Point)

    • 8.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.3 USA Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate2014-2019
    • 8.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.5 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.6 Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.7 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales and Growth, Sales Value and Growth Rate 2014-2019

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Research Center Industry
    • 11.2 Hospital Industry
    • 11.3 Clinic Industry

    12 Market Forecast 2020-2025

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
      • 12.1.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
      • 12.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units) and Growth Rate 2020-2025
      • 12.1.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.4 USA Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.5 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.6 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.7 Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.8 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.9 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.10 South America Squamous Non-Small Cell Lung Cancer Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2020-2025
      • 12.2.1 Overall Market Performance
      • 12.2.2 BMS-906024
      • 12.2.3 Buparlisib Hydrochloride
      • 12.2.4 FP-1039
      • 12.2.5 Ipilimumab
      • 12.2.6 JNJ-42756493
      • 12.2.7 Lenvatinib
      • 12.2.8 Others
    • 12.3 Sales (K Units) Forecast by Application 2020-2025
      • 12.3.1 Overall Market Performance
      • 12.3.2 Research Center
      • 12.3.3 Hospital
      • 12.3.4 Clinic
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price (USD/Unit) Trend 2020-2025
      • 12.4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Gross Profit Trend 2020-2025

    13 Conclusion

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Squamous Non-Small Cell Lung Cancer Therapeutics for these regions, from 2012 to 2023 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Squamous Non-Small Cell Lung Cancer Therapeutics market competition by top manufacturers/players, with Squamous Non-Small Cell Lung Cancer Therapeutics sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Ascenta Therapeutics, Inc.
    AstraZeneca Plc
    AVEO Pharmaceuticals, Inc.
    Bayer AG
    BIND Therapeutics, Inc.
    Boehringer Ingelheim GmbH
    Bristol-Myers Squibb Company
    Eli Lilly and Company
    F. Hoffmann-La Roche Ltd.
    Five Prime Therapeutics, Inc.
    Genentech, Inc.
    Incyte Corporation
    Johnson & Johnson
    MacroGenics, Inc.
    Novartis AG
    Oncogenex Pharmaceuticals, Inc.
    PsiOxus Therapeutics Limited
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BMS-906024
    Buparlisib Hydrochloride
    FP-1039
    Ipilimumab
    JNJ-42756493
    Lenvatinib
    Others
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Squamous Non-Small Cell Lung Cancer Therapeutics for each application, including
    Research Center
    Hospital
    Clinic

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now